In other words, tumour cell-derived PD-1 could exhaust the exogenous inhibitor of PD-1 and guarantee the combination of PD-L1 and PD-1 on T cell to inhibit T-cell activation and cytotoxicity [90]. Here, PDCD1 is linked to neoplasm.